These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21573834)

  • 1. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
    Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
    Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
    Oh CA; Bae JM; Oh SJ; Choi MG; Noh JH; Sohn TS; Kim S
    J Surg Oncol; 2012 Mar; 105(4):393-9. PubMed ID: 21898416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
    Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borrmann's type IV gastric cancer: clinicopathologic analysis.
    Yokota T; Teshima S; Saito T; Kikuchi S; Kunii Y; Yamauchi H
    Can J Surg; 1999 Oct; 42(5):371-6. PubMed ID: 10526523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
    Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
    Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
    Saito H; Kihara K; Kuroda H; Matsunaga T; Tatebe S; Ikeguchi M
    J Surg Oncol; 2011 Oct; 104(5):534-7. PubMed ID: 21618248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of peritoneal washing cytology in patients with gastric cancer.
    Lee SD; Ryu KW; Eom BW; Lee JH; Kook MC; Kim YW
    Br J Surg; 2012 Mar; 99(3):397-403. PubMed ID: 22101572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems of surgical management of Borrmann's type IV stomach cancer--with special reference to subdivision of Borrmann's type IV].
    Kito T
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2461-7. PubMed ID: 6651306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences.
    La Torre M; Ferri M; Giovagnoli MR; Sforza N; Cosenza G; Giarnieri E; Ziparo V
    Eur J Surg Oncol; 2010 Oct; 36(10):982-6. PubMed ID: 20591604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
    Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategy for patients with pN0 gastric carcinoma.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients.
    Mezhir JJ; Shah MA; Jacks LM; Brennan MF; Coit DG; Strong VE
    Ann Surg Oncol; 2010 Dec; 17(12):3173-80. PubMed ID: 20585870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.